Decreased cortical muscarinic M1 receptors in schizophrenia are associated with changes in gene promoter methylation, mRNA and gene targeting microRNA
Open Access
- 19 February 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Translational Psychiatry
- Vol. 3 (2), e230
- https://doi.org/10.1038/tp.2013.3
Abstract
Many studies have shown decreased cortical muscarinic M1 receptors (CHRM1) in schizophrenia (Sz), with one study showing Sz can be separated into two populations based on a marked loss of CHRM1 (∼75%) in ∼25% of people (Def-Sz) with the disorder. To better understand the mechanism contributing to the loss of CHRM1 in Def-Sz, we measured specific markers of gene expression in the cortex of people with Sz as a whole, people differentiated into Def-Sz and people with Sz that do not have a deficit in cortical CHRM1 (Non-Def-Sz) and health controls. We now report that cortical CHRM1 gene promoter methylation and CHRM1 mRNA are decrease in Sz, Def-Sz and Non-Def-Sz but levels of the micro RNA (miR)-107, a CHRM1 targeting miR, are increased only in Def-Sz. We also report in vitro data strongly supporting the notion that miR-107 levels regulate CHRM1 expression. These data suggest there is a reversal of the expected inverse relationship between gene promoter methylation and CHRM1 mRNA in people with Sz and that a breakdown in gene promoter methylation control of CHRM1 expression is contributing to the global pathophysiology of the syndrome. In addition, our data argues that increased levels of at least one miR, miR-107, is contributing to the marked loss of cortical CHRM1 in Def-Sz and this may be a differentiating pathophysiology. These latter data continue to support the hypothesis that microRNAs (miRNA) have a role in the underlying neurobiology of Sz but argue they are differentially affected in subsets of people within that syndrome.Keywords
This publication has 49 references indexed in Scilit:
- Epigenetic Mechanisms in Experience-Driven Memory Formation and BehaviorEpigenomics, 2011
- The Emerging Role of Epigenetics in StrokeArchives of Neurology, 2010
- Schizophrenia is associated with an increase in cortical microRNA biogenesisMolecular Psychiatry, 2009
- Disruptive insights in psychiatry: transforming a clinical disciplineJCI Insight, 2009
- Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disordersNature Reviews Drug Discovery, 2009
- Novel Selective Allosteric Activator of the M1Muscarinic Acetylcholine Receptor Regulates Amyloid Processing and Produces Antipsychotic-Like Activity in RatsJournal of Neuroscience, 2008
- GAD1 mRNA Expression and DNA Methylation in Prefrontal Cortex of Subjects with SchizophreniaPLOS ONE, 2007
- Human postmortem tissue: What quality markers matter?Brain Research, 2006
- miRGen: a database for the study of animal microRNA genomic organization and functionNucleic Acids Research, 2006
- No change in cortical muscarinic M2, M3 receptors or [35S]GTPγS binding in schizophreniaLife Sciences, 2006